European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Issue 10 (October 2022)
- Record Type:
- Journal Article
- Title:
- European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Issue 10 (October 2022)
- Main Title:
- European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
- Authors:
- Andratschke, Nicolaus
Willmann, Jonas
Appelt, Ane L
Alyamani, Najlaa
Balermpas, Panagiotis
Baumert, Brigitta G
Hurkmans, Coen
Høyer, Morten
Langendijk, Johannes A
Kaidar-Person, Orit
van der Linden, Yvette
Meattini, Icro
Niyazi, Maximilian
Reynaert, Nick
De Ruysscher, Dirk
Tanadini-Lang, Stephanie
Hoskin, Peter
Poortmans, Philip
Nieder, Carsten - Abstract:
- Summary: Re-irradiation can be considered for local recurrence or new tumours adjacent to a previously irradiated site to achieve durable local control for patients with cancer who have otherwise few therapeutic options. With the use of new radiotherapy techniques, which allow for conformal treatment plans, image guidance, and short fractionation schemes, the use of re-irradiation for different sites is increasing in clinical settings. Yet, prospective evidence on re-irradiation is scarce and our understanding of the underlying radiobiology is poor. Our consensus on re-irradiation aims to assist in re-irradiation decision making, and to standardise the classification of different forms of re-irradiation and reporting. The consensus has been endorsed by the European Society for Radiotherapy and Oncology and the European Organisation for Research and Treatment of Cancer. The use of this classification in daily clinical practice and research will facilitate accurate understanding of the clinical implications of re-irradiation and allow for cross-study comparisons. Data gathered in a uniform manner could be used in the future to make recommendations for re-irradiation on the basis of clinical evidence. The consensus document is based on an adapted Delphi process and a systematic review of the literature was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
- Is Part Of:
- Lancet oncology. Volume 23:Issue 10(2022)
- Journal:
- Lancet oncology
- Issue:
- Volume 23:Issue 10(2022)
- Issue Display:
- Volume 23, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 23
- Issue:
- 10
- Issue Sort Value:
- 2022-0023-0010-0000
- Page Start:
- e469
- Page End:
- e478
- Publication Date:
- 2022-10
- Subjects:
- Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1470-2045(22)00447-8 ↗
- Languages:
- English
- ISSNs:
- 1470-2045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23908.xml